Press Releases Seegene, Inc.

Equities

A096530

KR7096530001

End-of-day quote Korea S.E. Other stock markets 03:30:00 01/07/2024 am IST			5-day change	1st Jan Change
21,100 ^KRW	+5.50%		+4.20%	-7.86%

16/05	Seegene, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
14/03	Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Seegene and Springer Nature Announce Strategic Alliance	16/05	AQ
Seegene and UK Health Security Agency convene a summit to collectively realize 'a World Free from All Diseases'	09/04	AQ
Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"	08/04	AQ
Seegene and Springer Nature Announce Awardees for the Open Innovation Program	15/03	AQ
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'	24/01	AQ
Seegene obtains ISO45001 certification	27/12	AQ
Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability	10/11	AQ
Seegene Unveils 'Open Innovation Program Powered by Seegene' in Partnership with Springer Nature	04/23/04	AQ
Seegene declares to share Syndromic PCR technologies to prevent future pandemics	28/23/28	AQ
Seegene reports H1 2022 financial results	12/22/12	AQ
Seegene unveils strategies for global expansion at 2022 AACC	29/22/29	AQ
Seegene launches world's first In-life PCR campaign in Vietnam	19/22/19	AQ
Seegene to pave way for PCR testing at local clinics with EU-approved multiplex test and fully automated PCR solution	29/22/29	AQ
Seegene develops PCR test to detect monkeypox virus	28/22/28	AQ
Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic	25/22/25	AQ
Seegene reports first quarter 2022 financial results	13/22/13	AQ
Seegene unveils world's first commercialized '3 Ct' PCR assay	26/22/26	AQ
Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary	17/22/17	AQ
Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business	02/22/02	AQ
Seegene unveils new assay optimized for on-site testing in 'living with Covid-19' era	24/22/24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Seegene, Inc.

Equities

A096530

KR7096530001

Press Releases

Filters